about
Innovative trends and perspectives for erectile dysfunction treatment: A systematic reviewConservative treatment for Peyronie's disease: an update.Reversion of penile fibrosis: Current information and a new horizon.Erectile dysfunction in Arab countries. Part I: Prevalence and correlates.Venous grafting for the correction of penile curvature in Peyronie's disease.Lower urinary-tract symptoms and testosterone in elderly menImpact of the association between elevated oestradiol and low testosterone levels on erectile dysfunction severity.Erectile dysfunction, cardiovascular diseases and depression: interaction of therapy.Sexual selection and genital evolution: an overview.Cardiovascular aspects of sexual medicine.Cardiovascular diseases and erectile dysfunction: the two faces of the coin of androgen deficiency.Erectile dysfunction in Arab countries. Part II: Diagnosis and treatment.The pathophysiology of Peyronie's disease.What is the current role of intracavernosal injection in management of erectile dysfunction?Lower urinary tract symptoms in patients with erectile dysfunction: analysis of risk factors.Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model.Routine assessment of sperm DNA fragmentation in clinical practice: commentary and perspective.Traumatic arteriogenic erectile dysfunction: a rat model.An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression.Vascular impairment of erection in patients with diabetes and Peyronie's disease: is that accumulative?Coronary artery risk factors in patients with erectile dysfunction.Androgen pattern in patients with type 2 diabetes-associated erectile dysfunction: impact of metabolic control.Effect of cavernous nerve freezing on protein and gene expression of nitric oxide synthase in the rat penis and pelvic ganglia.Expression of TGF-beta-1 mRNA and ultrastructural alterations in pharmacologically induced prolonged penile erection in a canine model.Efficacy of sildenafil citrate in treatment of erectile dysfunction: impact of associated premature ejaculation and low desire.The effect of surgical trauma on rat tunica albuginea.Lower urinary tract symptoms in patients with erectile dysfunction: is there a vascular association?Intracavernosal prostaglandin E1 self vs office injection therapy in patients with erectile dysfunction.Sildenafil for erectile dysfunction in the Middle East: observational analysis of patients with diabetes and/or hypertension treated in the clinical practice setting.Characteristics of erectile dysfunction in Saudi patients.Pattern of endocrinal changes in patients with sexual dysfunction.The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction.Venous patch graft for Peyronie's disease. Part II: outcome analysis.Further experience with an operation for the cure of certain types of impotence. O.S. Lowsley, and A. Rueda.Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction.Alleviation of post-radical prostatectomy cavernosal fibrosis: future directions and potential utility for PDE5 inhibitors.Testosterone level and endothelial dysfunction in patients with vasculogenic erectile dysfunction.Association of risk factors and medical comorbidities with male sexual dysfunctions.Peyronie's disease in diabetic patients being screened for erectile dysfunction.Severity of erectile dysfunction at presentation: effect of premature ejaculation and low desire.
P50
Q26738907-A68AEAD7-30C3-440B-A9B8-A924001CFA2EQ33310054-A6DBCA06-D217-4526-98F4-369E14C3E162Q34502071-79B20F7F-CC52-4FBF-845E-75A5BB00AEB5Q35643022-940D8A48-2317-4124-BB03-C15402736ACAQ36622559-D40B078E-B2C9-4E96-BBBF-A34D021E4E6EQ36839032-D2D3AC5C-E863-488F-A6DD-F26154C8C135Q37084395-699408E7-D45D-4718-BD4F-95EBDE6E08E6Q37536049-AACAC2F6-5B1A-470F-A4AE-3FB189850AD1Q37705569-470741AF-0C76-4E54-B5ED-907A1B8430BFQ37730210-BFD1189F-128A-48D1-A6D5-0CC48ABEBB0DQ37827183-5A9B5E90-BD57-4AE6-BDBA-F5D37D842D4AQ38630381-490391EF-91D8-4A2B-A603-1A563F900AD0Q38630425-B094CCFB-D14C-458C-B1AB-AB2F76AC683DQ38807831-DB63F491-F9AF-4AED-B2D8-23B6B96A65EBQ38989361-8C7CBCC9-C371-4B2D-8608-2F5128C772CEQ41678876-52055B83-71BC-4BAA-B83F-D2992C4DD59CQ42693642-C01EFB56-DFC4-4037-81CA-30FCC4163510Q43721706-CDBAF3FA-906B-4F58-915D-350012F02781Q43758174-88621F4B-FF05-4744-997C-58F47E4E2482Q44462729-FF14FA84-8EDE-47D5-9EC3-7CA1C773F8BCQ44940138-345ED676-C713-401E-80AE-927D760D9909Q45932477-705EBCD6-CCF3-437A-BA34-321072D2F60EQ46004715-7F404032-673B-4ED3-A496-F0805BEC7BC0Q46083974-981AECBB-0DA4-4CE0-B33A-7703C62F60A2Q46279913-111FF046-C1AE-4A20-BDD7-DCAB800D4403Q46323132-47B6DEFE-7366-442B-BA60-71249FD4C1EDQ46553998-9D1C7464-B86E-4D97-B17C-5368D177AB13Q46703697-B8ABDE74-C573-4C4C-B429-FB9E5E21F029Q46794096-CCCBC6C9-21EF-4AA2-BAC0-5A42C05B9133Q46889713-03869F42-CB4D-484C-AF3C-B0AF1CF8F3ECQ46901066-ACDAA890-E632-41D8-9E01-11B13595321AQ46923290-D6BB69C5-E962-46BB-B77B-67D2453C673BQ46933341-E8D230DA-A7A4-43B5-8CC2-EFEDD5669008Q49082346-6886673E-FE45-4193-ABA9-5BF37000363BQ51463231-520117D5-0156-4909-9C33-EC48976D710EQ51686276-CA793848-33E2-46C7-BA24-D67EBFE87CE1Q51828476-ED02686E-049B-4FCA-93E4-72B8148B95FEQ51910564-E726AE47-B534-4A94-810C-80E2D6D7221EQ51966668-4412C9B3-6B3D-4463-8D7A-A1B5E902AD63Q53221201-F204FAB9-106C-4C62-BDA5-04B552BAFD62
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ahmed I El-Sakka
@ast
Ahmed I El-Sakka
@en
Ahmed I El-Sakka
@es
Ahmed I El-Sakka
@nl
Ahmed I El-Sakka
@sl
type
label
Ahmed I El-Sakka
@ast
Ahmed I El-Sakka
@en
Ahmed I El-Sakka
@es
Ahmed I El-Sakka
@nl
Ahmed I El-Sakka
@sl
prefLabel
Ahmed I El-Sakka
@ast
Ahmed I El-Sakka
@en
Ahmed I El-Sakka
@es
Ahmed I El-Sakka
@nl
Ahmed I El-Sakka
@sl
P106
P21
P31
P496
0000-0001-8671-5952